Auxiliary Diagnosis of Lung Cancer with Magnetic Resonance Imaging Data under Deep Learning

被引:4
作者
Xia, Lei [1 ]
机构
[1] Second Affiliated Hosp Chongqing Med Univ, Canc Ctr, Chongqing 400000, Peoples R China
关键词
MRI; NSCLC;
D O I
10.1155/2022/1994082
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study was aimed at two image segmentation methods of three-dimensional (3D) U-shaped network (U-Net) and multilevel boundary sensing residual U-shaped network (RUNet) and their application values on the auxiliary diagnosis of lung cancer. In this study, on the basis of the 3D U-Net segmentation method, the multilevel boundary sensing RUNet was worked out after optimization. 92 patients with lung cancer were selected, and their clinical data were counted; meanwhile, the lung nodule detection was performed to obtain the segmentation effect under 3D U-Net. The accuracy of 3D U-Net and multilevel boundary sensing RUNet was compared on lung magnetic resonance imaging (MRI) after lung nodule segmentation. Patients with benign lung tumors were taken as controls; the blood immune biochemical indicators progastrin-releasing peptide (pro-CRP), carcinoembryonic antigen (CEA), and neuron-specific enolase (NSE) in patients with malignant lung tumors were analyzed. It was found that the accuracy, sensitivity, and specificity were all greater than 90% under the algorithm-based MRI of benign and malignant tumor patients. Based on the imaging signs for the MRI image of lung nodules, the segmentation effect of the RUNet was clearer than that of the 3D U-Net. In addition, serum levels of pro-CRP, NSE, and CAE in patients with benign lung tumors were 28.9 pg/mL, 12.5 ng/mL, and 10.8 ng/mL, respectively, which were lower than 175.6 pg/mL, 33.6 ng/mL, and 31.9 ng/mL in patients with malignant lung tumors significantly (P < 0.05). Thus, the RUNet image segmentation method was better than the 3D U-Net. The pro-CRP, CEA, and NSE could be used as diagnostic indicators for malignant lung tumors.
引用
收藏
页数:7
相关论文
共 25 条
[1]   Image-guided radiotherapy in lung cancer [J].
Aboudaram, A. ;
Khalifa, J. ;
Massabeau, C. ;
Sirrion, L. ;
Henni, A. Hadj ;
Thureau, S. .
CANCER RADIOTHERAPIE, 2018, 22 (6-7) :602-607
[2]   Cost-effectiveness of lung MRI in lung cancer screening [J].
Allen, Bradley D. ;
Schiebler, Mark L. ;
Sommer, Gregor ;
Kauczor, Hans-Ulrich ;
Biederer, Juergen ;
Kruser, Timothy J. ;
Carr, James C. ;
Hazen, Gordon .
EUROPEAN RADIOLOGY, 2020, 30 (03) :1738-1746
[3]   Multi disease-prediction framework using hybrid deep learning: an optimal prediction model [J].
Ampavathi, Anusha ;
Saradhi, T. Vijaya .
COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING, 2021, 24 (10) :1146-1168
[4]   Screening for lung cancer: Does MRI have a role? [J].
Biederer, Juergen ;
Ohno, Yoshiharu ;
Hatabu, Hiroto ;
Schiebler, Mark L. ;
van Beek, Edwin J. R. ;
Vogel-Claussen, Jens ;
Kauczor, Hans-Ulrich .
EUROPEAN JOURNAL OF RADIOLOGY, 2017, 86 :353-360
[5]   Adjuvant and Neoadjuvant Immunotherapy in Non - small Cell Lung Cancer [J].
Broderick, Stephen R. .
THORACIC SURGERY CLINICS, 2020, 30 (02) :215-+
[6]   Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines [J].
Carolina Martinez-Torres, Ana ;
Gomez-Morales, Luis ;
Martinez-Loril, Alan B. ;
Concepcion Uscanga-Palomeque, Ashanti ;
Manuel Vazquez-Guillen, Jose ;
Rodriguez-Padilla, Cristina .
PEERJ, 2019, 7
[7]   Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging [J].
Chi, Yi-Hsuan ;
Hsiao, Jong-Kai ;
Lin, Ming-Huang ;
Chang, Chen ;
Lan, Chun-Hsin ;
Wu, Han-Chung .
THERANOSTICS, 2017, 7 (06) :1612-1632
[8]   Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules-a literature review [J].
Dahlsgaard-Wallenius, Sara E. ;
Hildebrandt, Malene Grubbe ;
Johansen, Allan ;
Vilstrup, Mie Holm ;
Petersen, Henrik ;
Gerke, Oke ;
Hoilund-Carlsen, Poul Flemming ;
Morsing, Anni ;
Andersen, Thomas Lund .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (02) :584-591
[9]   The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients [J].
Dal Bello, M. G. ;
Filiberti, R. A. ;
Alama, A. ;
Orengo, A. M. ;
Mussap, M. ;
Coco, S. ;
Vanni, I. ;
Boccardo, S. ;
Rijavec, E. ;
Genova, C. ;
Biello, F. ;
Barletta, G. ;
Rossi, G. ;
Tagliamento, M. ;
Maggioni, C. ;
Grossi, F. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17
[10]   Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations [J].
Evans, Ruth E. C. ;
Taylor, Stuart A. ;
Beare, Sandra ;
Halligan, Steve ;
Morton, Alison ;
Oliver, Alf ;
Rockall, Andrea ;
Miles, Anne .
BRITISH JOURNAL OF RADIOLOGY, 2018, 91 (1086)